Heslington, United Kingdom

Arnold B Lambert

This inventor holds 1 USPTO granted patent. Top assignee: Solvay (Societe Anonyme). Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnold B Lambert: Innovator in Chemical Processes

Introduction

Arnold B Lambert is a notable inventor based in Heslington, GB. He has made significant contributions to the field of chemical engineering, particularly in the oxidation processes of organic compounds. His work has implications for various industrial applications, showcasing the importance of innovation in chemistry.

Latest Patents

Arnold B Lambert holds a patent for a process related to the oxidation of cyclohexanone to ε-caprolactone. This invention involves a composition comprising antimony trifluoride and silica, along with a method for preparing this composition. The use of this composition as a catalyst in the oxidation process highlights Lambert's innovative approach to enhancing chemical reactions.

Career Highlights

Throughout his career, Lambert has been associated with Solvay, a prominent chemical company. His work at Solvay has allowed him to explore and develop new chemical processes that contribute to the advancement of the industry. His expertise in catalysis and oxidation processes has positioned him as a valuable asset in his field.

Collaborations

Arnold B Lambert has collaborated with notable colleagues, including Michael C Rocca and Graham Carr. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and innovation in chemical research.

Conclusion

Arnold B Lambert's contributions to the field of chemical engineering, particularly through his patent on the oxidation of cyclohexanone, demonstrate his commitment to innovation. His work continues to influence the industry and inspire future advancements in chemical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…